PMC:1208879 / 15127-15356 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T3829 0-2 VBN denotes ed
T3828 0-229 sentence denotes ed that HOMER3, DNCL1 and TRIM11 interact with the PAX6 PST domain, we next investigated how the interactions were affected by three C-terminal PAX6 mutations that have been previously described in patients with ocular anomalies.
T3831 3-7 IN denotes that
T3833 8-14 NN denotes HOMER3
T3834 14-16 , denotes ,
T3835 16-21 NN denotes DNCL1
T3836 22-25 CC denotes and
T3837 26-32 NN denotes TRIM11
T3832 33-41 VBP denotes interact
T3838 42-46 IN denotes with
T3839 47-50 DT denotes the
T3841 51-55 NN denotes PAX6
T3842 56-59 NN denotes PST
T3840 60-66 NN denotes domain
T3843 66-68 , denotes ,
T3844 68-70 PRP denotes we
T3845 71-75 RB denotes next
T3830 76-88 VBD denotes investigated
T3846 89-92 WRB denotes how
T3848 93-96 DT denotes the
T3849 97-109 NNS denotes interactions
T3850 110-114 VBD denotes were
T3847 115-123 VBN denotes affected
T3851 124-126 IN denotes by
T3852 127-132 CD denotes three
T3854 133-134 NN denotes C
T3856 134-135 HYPH denotes -
T3855 135-143 JJ denotes terminal
T3857 144-148 NN denotes PAX6
T3853 149-158 NNS denotes mutations
T3858 159-163 WDT denotes that
T3860 164-168 VBP denotes have
T3861 169-173 VBN denotes been
T3862 174-184 RB denotes previously
T3859 185-194 VBN denotes described
T3863 195-197 IN denotes in
T3864 198-206 NNS denotes patients
T3865 207-211 IN denotes with
T3866 212-218 JJ denotes ocular
T3867 219-228 NNS denotes anomalies
T3868 228-229 . denotes .
R2316 T3829 T3830 advcl ed,investigated
R2317 T3831 T3832 mark that,interact
R2318 T3832 T3829 ccomp interact,ed
R2319 T3833 T3832 nsubj HOMER3,interact
R2320 T3834 T3833 punct ", ",HOMER3
R2321 T3835 T3833 conj DNCL1,HOMER3
R2322 T3836 T3835 cc and,DNCL1
R2323 T3837 T3835 conj TRIM11,DNCL1
R2324 T3838 T3832 prep with,interact
R2325 T3839 T3840 det the,domain
R2326 T3840 T3838 pobj domain,with
R2327 T3841 T3840 compound PAX6,domain
R2328 T3842 T3840 compound PST,domain
R2329 T3843 T3830 punct ", ",investigated
R2330 T3844 T3830 nsubj we,investigated
R2331 T3845 T3830 advmod next,investigated
R2332 T3846 T3847 advmod how,affected
R2333 T3847 T3830 ccomp affected,investigated
R2334 T3848 T3849 det the,interactions
R2335 T3849 T3847 nsubjpass interactions,affected
R2336 T3850 T3847 auxpass were,affected
R2337 T3851 T3847 agent by,affected
R2338 T3852 T3853 nummod three,mutations
R2339 T3853 T3851 pobj mutations,by
R2340 T3854 T3855 npadvmod C,terminal
R2341 T3855 T3853 amod terminal,mutations
R2342 T3856 T3855 punct -,terminal
R2343 T3857 T3853 compound PAX6,mutations
R2344 T3858 T3859 dep that,described
R2345 T3859 T3853 relcl described,mutations
R2346 T3860 T3859 aux have,described
R2347 T3861 T3859 auxpass been,described
R2348 T3862 T3859 advmod previously,described
R2349 T3863 T3859 prep in,described
R2350 T3864 T3863 pobj patients,in
R2351 T3865 T3864 prep with,patients
R2352 T3866 T3867 amod ocular,anomalies
R2353 T3867 T3865 pobj anomalies,with
R2354 T3868 T3830 punct .,investigated